BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 27514595)

  • 1. α1-Antitrypsin Deficiency.
    Hatipoğlu U; Stoller JK
    Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B; Ferrarotti I; Miravitlles M
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha1-antitrypsin review.
    Stockley RA
    Clin Chest Med; 2014 Mar; 35(1):39-50. PubMed ID: 24507836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-1 antitrypsin deficiency 50 years later].
    Mornex JF
    Bull Acad Natl Med; 2014; 198(4-5):757-66. PubMed ID: 26753407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema.
    Mahadeva R; Lomas DA
    Thorax; 1998 Jun; 53(6):501-5. PubMed ID: 9713452
    [No Abstract]   [Full Text] [Related]  

  • 10. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung disease due to alpha 1-antitrypsin deficiency.
    Wiedemann HP; Stoller JK
    Curr Opin Pulm Med; 1996 Mar; 2(2):155-60. PubMed ID: 9363132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1-antitrypsin deficiency: incidence and implications.
    Richmond RJ; Zellner KM
    Dimens Crit Care Nurs; 2005; 24(6):255-60; quiz 261-2. PubMed ID: 16327507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Practical applications of recombinant alpha-1-antitrypsin in medicine].
    Kabziński J; Kedziora J; Majsterek I
    Pol Merkur Lekarski; 2010 Dec; 29(174):345-50. PubMed ID: 21298982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
    Fregonese L; Stolk J
    Orphanet J Rare Dis; 2008 Jun; 3():16. PubMed ID: 18565211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies.
    Ferrarotti I; Corsico AG; Stolk J; Ottaviani S; Fumagalli M; Janciauskiene S; Iadarola P
    COPD; 2017 Feb; 14(1):56-65. PubMed ID: 27827549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.